Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma. - Rimassa L; Kelley RK; Meyer T; Ryoo BY; Merle P; Park JW; Blanc JF; Lim HY; Tran A; Chan YW; McAdam P; Wang E; et al. (Liver cancer, 2021)